OXIS International, Inc. (OTCMKTS:OXIS) subsidiary firm OXIS Biotech, Inc. executed an exclusive option deal with the University of Pittsburgh. The agreement is associated with certain intellectual properties and patents developed by Dr. Xiang-Qun Xie.

The patents

These patents and intellectual properties are associated with the novel and unique compositions-of-matter which could be useful as medications for the treatment of several human diseases. The term of the exclusive option deal is eighteen months. In this period, the University of Pittsburgh will not provide third entities the opportunity to license these patents and intellectual properties.

The details

Anthony J. Cataldo, the CEO of subsidiary company of OXIS, said that the company is delighted to get the opportunity to include University of Pittsburgh intellectual properties rights to the company’s existing portfolio. OXIS Biotech’s main drug candidate named as OXS-4235 was developed by Dr. Xie and his team.

The performance

OXIS International, Inc. (OTCMKTS:OXIS) managed to add more than 7% to its market value yesterday, but the question is that how long will positive turn of events last? The addition of Dr. Sean Xie, Dr. Lisa A Haile and Dr. James Mule to Scientific Advisory Board resulted in strong gains for the company.

The financials

The financial numbers of OXIS are not supportive of its development plans. As per last 10-Q filed, it had cash of $664,000, total current assets of $690, 000 and total current liabilities were $11.3 million. The liabilities are massive with cash balance at lower side to support the ongoing activities. The revenue in quarter was $3,000 and net loss stood at $4.2 million. It is certainly significant that these financial numbers are of a company whose market capitalization is currently $25 million. OXIS International has an accumulated deficit of $94 million. The management will hold a conference call on March 31 to provide further operational updates.

Previous articleCyclone Power Technologies Inc (OTCMKTS:CYPW) Updates On Progress Of Cyclone Engines
Next articleFederal Home Loan Mortgage Corp (OTCBB:FMCC) Likely To Remain Under U.S. Conservatorship
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.